Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pain Control for Undergoing Costal Cartilage Harvesting
Sponsor: Mayo Clinic
Summary
The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.
Official title: A Phase IV Randomized, Single-Blind Trial of Liposomal Bupivacaine (Exparel®) for Pain Control in Costal Cartilage Harvest
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2022-05-04
Completion Date
2026-09
Last Updated
2025-09-12
Healthy Volunteers
Yes
Conditions
Interventions
Exparel
106mg (8 mL) subcutaneous injection injected after costal cartilage harvest
Xylocaine
8 mL of 1% lidocaine with 1:100,000 of epinephrine into costal cartilage wound site
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States